|
(P206) |
Substrate-based ablation of ventricular tachycardia: differences of efficacy and outcome in patients with DCM and ICM |
|
|
P. Lugenbiel, F. Langkamp, P. Schweizer, D. Thomas, H. A. Katus, E. P. Scholz (Heidelberg) |
|
(P207) |
Heart Mate 3™ left ventricular assist device and implantable cardiac devices -device interactions and cardiac arrhythmias during a one-year follow-up |
|
|
V. Rubesch-Kütemeyer, P. Sommer, J. Gummert, V. Rudolph, M. Morshuis, H. Fox (Bad Oeynhausen) |
|
(P208) |
Characterization of the arrhythmogenic substrate in patients with scar-related ventricular tachycardia: importance of high-resolution mapping |
|
|
A.-K. Kahle, J. M. Schwarzl, P. Münkler, N. Klatt, M. Schwarzl, L. Kaiser, B. Schäffer, P. Kuklik, R. Ö. Akbulak, J. Moser, M. Jularic, C. Eickholt, S. Willems, C. Meyer (Hamburg) |
|
(P209) |
Cardiac stereotactic radiotherapy in ventricular arrhythmia storm: A single center experience |
|
|
E. P. Scholz, K. Seidensaal, B. Rhein, F. André, P. Naumann, P. Lugenbiel, E. Tonndorf-Martini, J. Riffel, H. A. Katus, J. Debus (Heidelberg) |
|
(P210) |
Ablation of ventricular arrhythmia in patients with ischemic cardiomyopathy: May we suspect a homogenous patient population? |
|
|
M. Kornmayer, S. Brooks, K. Koch-Büttner, E. Risse, M. Kottmaier, F. Bourier, T. Reents, G. Heßling, I. Deisenhofer (München) |
|
(P211) |
Ablation of ventricular arrhythmia in octogenarians: A single centre experience |
|
|
M. Kornmayer, S. Brooks, K. Koch-Büttner, E. Risse, M. Kottmaier, F. Bourier, T. Reents, G. Heßling, I. Deisenhofer (München) |
|
(P212) |
Assessing procedural safety and in-hospital mortality after catheter ablation of ventricular arrhythmias: The Risk In VT Ablation (RIVA) score. |
|
|
T. Fink, S. Feickert, M. Schlüter, E. Wißner, R. R. Tilz, V. Sciacca, C.-H. Heeger, L. Rottner, B. Reissmann, A. Rillig, A. Metzner, C. Lemes, T. Maurer, K.-H. Kuck, F. Ouyang, S. Mathew (Hamburg, Lübeck; Chicago, IL, US) |
|
(P213) |
Ventricular tachycardia ablation in non-ischemic heart disease: Lessons from 4 years clinical follow-up. |
|
|
T. Fink, M. Schlüter, B. Schmidt, C.-H. Heeger, B. Reissmann, V. Sciacca, S. Mathew, A. Metzner, A. Rillig, F. Ouyang, K.-H. Kuck, R. R. Tilz (Hamburg, Frankfurt am Main, Lübeck) |